Zhejiang Medicine Co Ltd
SSE:600216

Watchlist Manager
Zhejiang Medicine Co Ltd Logo
Zhejiang Medicine Co Ltd
SSE:600216
Watchlist
Price: 16.15 CNY -0.92% Market Closed
Market Cap: 15.5B CNY
Have any thoughts about
Zhejiang Medicine Co Ltd?
Write Note
Zhejiang Medicine Co Ltd
/
Cash Flow Statement
/
Cash from Financing Activities

Zhejiang Medicine Co Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zhejiang Medicine Co Ltd
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Zhejiang Medicine Co Ltd
SSE:600216
Cash from Financing Activities
-¥255.1m
CAGR 3-Years
4%
CAGR 5-Years
-34%
CAGR 10-Years
-13%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cash from Financing Activities
-¥753.7m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cash from Financing Activities
-¥2.1B
CAGR 3-Years
-48%
CAGR 5-Years
-52%
CAGR 10-Years
-26%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cash from Financing Activities
-¥1.6B
CAGR 3-Years
-84%
CAGR 5-Years
-15%
CAGR 10-Years
-105%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cash from Financing Activities
-¥3.4B
CAGR 3-Years
11%
CAGR 5-Years
16%
CAGR 10-Years
-24%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Cash from Financing Activities
¥90.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Zhejiang Medicine Co Ltd
Glance View

Market Cap
15.5B CNY
Industry
Pharmaceuticals

Zhejiang Medicine Co., Ltd., a stalwart in the pharmaceutical industry, traces its roots back to a time when China's economic landscape was rapidly transforming. Founded amidst the burgeoning wave of Chinese industrial expansion, the company made a calculated entry into the biopharmaceutical sector, a move that positioned it as an indispensable player in the realm of vitamins and antibiotics. Headquartered in the populous province of Zhejiang, the firm quickly honed its expertise in the manufacturing and export of fat-soluble vitamins, notably vitamin E, which became one of its hallmark products. Their robust production facilities and rigorous adherence to quality standards have not only fueled domestic demand but also secured a strong foothold in international markets, particularly Europe and the Americas. Zhejiang Medicine has crafted a diversified portfolio that spans active pharmaceutical ingredients (APIs) and advanced intermediates, offering a spectrum of products utilized by various health and pharmaceutical companies worldwide. A key revenue driver for the company lies in its vertical integration strategy, which enables it to maintain meticulous oversight over the entire production process, from raw materials to finished goods. The company’s commitment to R&D is evident in its investments in technology and innovation, allowing it to improve production efficiency and develop new compounds that cater to the evolving demands of the health sector. This approach not only insulates the company from market volatility but also fortifies its competitive position in a dynamic industry.

Intrinsic Value
17.49 CNY
Undervaluation 8%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Zhejiang Medicine Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-255.1m CNY

Based on the financial report for Sep 30, 2024, Zhejiang Medicine Co Ltd's Cash from Financing Activities amounts to -255.1m CNY.

What is Zhejiang Medicine Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-13%

Over the last year, the Cash from Financing Activities growth was -43%. The average annual Cash from Financing Activities growth rates for Zhejiang Medicine Co Ltd have been 4% over the past three years , -34% over the past five years , and -13% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.